In addition to the fusion gene-producing translocations given in the table, "ETV6" has been reported to fuse with other genes in very rare cases (i.e. 1-10 published reports). These translocations lead to one or more of the same types of hematological malignancies listed in the table. Thus, the "ETV6" gene reportedly forms translocation-induced fusion genes with: a) tyrosine kinase receptor gene "FGFR3"; b) non-receptor tyrosine kinase genes "ABL2, NTRK3, JAK2, SYK, FRK," and "LYN"; c) transcription factor genes "MN1" and "PER1"; d) homeobox protein transcription factor "CDX2"; e) Protein tyrosine phosphatase receptor-type R gene "PTPRR"; f) transcriptional coactivator for nuclear hormone receptors gene NCOA2; f) Immunoglobulin heavy chain gene IGH; g) enzyme genes "TTL" (adds and removes tyrosine residues on α-tubulin), "GOT1" (an Aspartate transaminase), and ACSL6 (a Long-chain-fatty-acid—CoA ligase); h) transporter gene "ARNT" (binds to ligand-bound aryl hydrocarbon receptor to aid in its movement to the nucleus where it promotes the expression of genes involved in xenobiotic metabolism); i) unknown function genes "CHIC2", "MDS2", FCHO2 and "BAZ2A".; and j) non-annotated gene "STL" (which has no long open reading frame).